A Novel Hemoglobin-Based Oxygen Carrier, Polymerized Porcine Hemoglobin, Inhibits H2O2-Induced Cytotoxicity of Endothelial Cells

Artificial Organs

Volumn 36, Issue 2, 2012, Pages 151-160

  Zhang, Wei ^a,c   Yan, Kunping ^a,b   Dai, Penggao ^a   Tian, Jingjing ^a   Zhu, Hongli ^a   Chen, Chao ^a  

^a NORTHWEST UNIVERSITY   (China)

^b Shaanxi Lifegen Co Ltd   (China)

^c JILIN MEDICAL COLLEGE   (China)

Author keywords

Catalase; Cytotoxicity; Hemoglobin based oxygen carriers; Human umbilical vein endothelial cell line; Hydrogen peroxide; Polymerized porcine hemoglobin; Superoxide dismutase

Indexed keywords

CELL CULTURE; CELL DEATH; CYTOTOXICITY; ENDOTHELIAL CELLS; FREE RADICALS; HEMOGLOBIN; OXYGEN;

CATALASE; ENDOTHELIAL CELL LINE; ENDOTHELIAL-CELLS; HAEMOGLOBINS; HEMOGLOBIN-BASED OXYGEN CARRIERS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELL LINE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; POLYMERIZED PORCINE HEMOGLOBIN; SUPER OXIDE DISMUTASE; SUPEROXIDE DISMUTASES;

ENZYMES;

CATALASE; ENDOTOXIN; HEMOGLOBIN; HEMOGLOBIN BASED OXYGEN CARRIER; HYDROGEN PEROXIDE; METHEMOGLOBIN; POLYMERIZED PORCINE HEMOGLOBIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL DAMAGE; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ERYTHROCYTE TRANSFUSION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INHIBITION KINETICS; OSMOLALITY; PH; POLYMERIZATION; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SWINE; UMBILICAL VEIN ENDOTHELIAL CELL;

SUS;

EID: 84857072201     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2011.01305.x     Document Type: Article

References (41)

1. Chang T. Blood Substitutes: Principles, Methods, Products and Clinical Trials, Vol. 1. New York: Karger Landes, 1997.
2. Winslow RM. Current status of oxygen carriers ("blood substitutes"): 2006. Vox Sang 2006;91:102-10.
3. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 1997;22:269-85.
4. Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 1997;15:351-69.
5. Zheng M, Aslund F, Storz G. Activation of the OxyR transcription factor by reversible disulfide bond formation. Science 1998;279:1718-21.
6. Aslund F, Beckwith J. Bridge over troubled waters: sensing stress by disulfide bond formation. Cell 1999;96:751-3.
7. Pierce GB, Parchment RE, Lewellyn AL. Hydrogen peroxide as a mediator of programmed cell death in the blastocyst. Differentiation 1991;46:181-6.
8. Novogrodsky A, Ravid A, Rubin AL, Stenzel KH. Hydroxyl radical scavengers inhibit lymphocyte mitogenesis. Proc Natl Acad Sci USA 1982;79:1171-4.
9. Murrell GA, Francis MJ, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 1990;265:659-65.
10. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995;18:775-94.
11. Lennon SV, Martin SJ, Cotter TG. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 1991;24:203-14.
12. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:C1424-37.
13. Granger DN, Korthuis RJ. Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol 1995;57:311-32.
14. Jabs T. Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol 1999;57:231-45.
15. McConkey DJ. Biochemical determinants of apoptosis and necrosis. Toxicol Lett 1998;99:157-68.
16. Patel RP, McAndrew J, Sellak H, etal. Biological aspects of reactive nitrogen species. Biochim Biophys Acta 1999;1411:385-400.
17. Giulivi C, Cadenas E. Heme protein radicals: formation, fate, and biological consequences. Free Radic Biol Med 1998;24:269-79.
18. Dalziel K, O'Brien JR. Side reactions in the deoxygenation of dilute oxyhaemoglobin solutions by sodium dithionite. Biochem J 1957;67:119-24.
19. Giulivi C, Davies KJA. Hydrogen peroxide-mediated ferrylhemoglobin generation in vitro and in red blood cells. Methods Enzymol 1994;231:490-6.
20. Goldman DW, Breyer RJ 3rd, Yeh D, Brockner-Ryan BA, Alayash AI. Acellular hemoglobin-mediated oxidative stress toward endothelium: a role for ferryl iron. Am J Physiol 1998;275:H1046-53.
21. Reeder BJ, Sharpe MA, Kay AD, etal. Toxicity of myoglobin and haemoglobin: oxidative stress in patients with rhabdyomyolysis and subarachnoid haemorrhage. Biochem Soc Trans 2002;30:745-8.
22. Widmer CC, Pereira CP, Gehrig P, etal. Hemoglobin can attenuate hydrogen peroxide-induced oxidative stress by acting as an antioxidative peroxidase. Antioxid Redox Signal 2010;12:185-98.
23. Gu J, Chang TM. Extraction of erythrocyte enzymes for the preparation of polyhemoglobin-catalase-superoxide dismutase. Artif Cells Blood Substit Immobil Biotechnol 2009;37:69-77.
24. Zhu HL, Du QQ, Chen C, Chang TMS. The immunological properties of stroma-free polyhemolysate containing catalase and superoxide dismutase activities prepared by polymerized bovine stroma-free hemolysate. Artif Cells Blood Substit Immobil Biotechnol 2010;38:56-61.
25. Ferinstein RN. Perborate as substrate in a new assay of catalase. J Biol Chem 1949;18:1197-202.
26. Fossati P, Prencipe L, Berti G. Use of 3, 5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem 1980;26:227-31.
27. Ying YW, Wei YS, etal. Chinese National Clinical Labortary Precedures Version 3. Chapter III. Beijing: People's Health Publishing House, 2007, pp. 56-7.
28. Berzofsky JA, Peisach J, Blumberg WE. Sulfheme proteins. I. Optical and magnetic properties of sulfmyoglobin and its derivatives. J Biol Chem 1972;246:3367-77.
29. Haney CR, Buehler PW, Gulati A. Purification and chemical modifications of hemoglobin in developing hemoglobin based oxygen carriers. Adv Drug Deliv Rev 2000;40:153-69.
30. Baldwin AL. Blood substitutes and redox responses in the mirocirculation. Antioxid Redox Signal 2005;6:1019-30.
31. Winslow RM. Toxicity and side effects ("blood substitutes"): 2006. Vox Sang 2006;91:197-205.
32. D'Agnillo F, Alayash AI. Interactions of hemoglobin with hydrogen peroxide alters thiol levels and course of endothelial cell death. Am J Physiol Heart Circ Physiol 2000;279:H1880-9.
33. D'Agnillo F, Wood F, Porras C, Macdonald VW, Alayash AI. Effects of hypoxia and glutathione depletion on hemoglobin- and myoglobin-mediated oxidative stress toward endothelium. Biochim Biophys Acta 2000;1495:150-9.
34. Simoni J. Endothelial cell response to hemoglobin based oxygen carriers. Is the attenuation of pathological reactions possible? In: Kobayashi K, Tsuchida E, Horinouchi H, eds. Artificial Oxygen Carrier. Its Front Line. Tokyo: Springer-Verlag, 2005;75-125.
35. Simoni J, Simoni G, Lox CD, Feola M. Reaction of human endothelial cells to bovine hemoglobin and tumor necrosis factor. Artif Cells Blood Substit Immobil Biotechnol 1994;22:777-87.
36. Simoni J, Simoni G, Martinez-Zaguilan R, etal. Improved blood substitute: evaluation of its effects on human endothelial cells. ASAIO J 1998;45:M356-67.
37. Simoni J, Villanueva-Meyer J, Simoni G, etal. Control of oxidative reactions of hemoglobin in the design of blood substitutes: role of the ascorbate-glutathione antioxidant system. Artif Organs 2009;33:115-26.
38. Alayash AI. Oxygen therapeutics: can we tame haemoglobin? Nat Rev Drug Discov 2004;3:152-9.
39. D'Agnillo F, Chang TM. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat Biotechnol 1998;16:667-71.
40. D'Agnillo F, Alayash AI. Redox cycling of diaspirin cross-linked hemoglobin induces G2/M arrest and apoptosis in cultured endothelial cells. Blood 2001;98:3315-23.
41. Li T, Li J, Liu J, etal. Polymerized placenta hemoglobin attenuates ischemia/reperfusion injury and restores the nitroso-redox balance in isolated rat heart. Free Radic Biol Med 2009;46:397-405.